Candela Corporation is the lead sponsor of 5 current clinical trials in our USA, UK, Netherlands, Spain, Canada and Israel registers. None of its ClinicalTrials.gov trials is recruiting at the moment. All registered phases are Not applicable. The most-studied condition is Wrinkle.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Clinical Study to Evaluate the Efficacy and Safety of Matrix Pro Treatment
NCT06726122 · ClinicalTrials.gov ↗ · Skin Laxity, Wrinkle, Skin Condition
|
Not applicable | By invitation | 2025-01 | UK, Netherlands |
|
Safety and Efficacy of Matrix Pro for Eyebrow Lift and Lift of Submental/Neck Laxity
NCT06640998 · ClinicalTrials.gov ↗ · Laxity; Skin
|
Not applicable | By invitation | 2024-09 | USA |
|
Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD
NCT06064071 · Meibomian Gland Dysfunction, Dry Eye Disease
|
Not applicable | Active, closed | 2023-09 | USA |
|
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
NCT06202274 · ClinicalTrials.gov ↗ · Hair Reduction, Tattoo Removal, Wrinkle
|
Not applicable | Active, closed | 2023-10 | USA, Israel |
|
Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System
NCT06157567 · ClinicalTrials.gov ↗ · Skin Laxity, Wrinkle, Skin Condition
|
Not applicable | Active, closed | 2022-05 | USA, Spain, Canada |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 4 | 0 |
| Clinical trials in UK | 1 | 0 |
| Clinical trials in Netherlands | 1 | 0 |
| Clinical trials in Spain | 1 | 0 |
| Clinical trials in Canada | 1 | 0 |
| Clinical trials in Israel | 1 | 0 |
A trial with sites in more than one country appears in each of those registers.
| Sponsor | Trials |
|---|---|
| AVAVA | 2 |
| Innate | 1 |
Sponsors with the most current trials registered for this condition.
Candela Corporation is the lead sponsor of 5 current trials on ClinicalTrials.gov in our USA, UK, Netherlands, Spain, Canada and Israel registers, as of the registry sync on 27 September 2026. Completed and withdrawn studies are not counted.
Not at the moment. None of its 5 ClinicalTrials.gov trials is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 27 Sep 2026.